Subject of Possible Rule Making: WAC 182-531-2040 Enhanced reimbursement—Medication assisted treatment for opioid use disorder; other related rules as appropriate.

Reasons Why Rules on this Subject may be Needed and What They Might Accomplish: The health care authority (agency) is revising these rules to change the title of the rule section to Enhanced reimbursement—Medication for opioid use disorder (MOUD). The agency is also revising the section to clarify the requirements for receiving the enhanced reimbursement for MOUD. During the course of this review, the agency may identify additional related changes that are required in order to improve clarity or update policy.

Other Federal and State Agencies that Regulate this Subject and the Process Coordinating the Rule with These Agencies: Centers for Medicare and Medicaid Services.

Process for Developing New Rule: The agency welcomes the public to take part in developing this rule. If interested, contact the person identified below to receive an early rule draft to review. After the early review, the agency will send a notice of proposed rule making (CR-102) to everyone receiving this notice and anyone who requests a copy.

Interested parties can participate in the decision to adopt the new rule and formulation of the proposed rule before publication by contacting Jason Crabbe, Rule-Making Questions, P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-9563, fax 360-586-9727, telecommunication relay services (TRS) 711, email jason.crabbe@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking; or Andrea Allen, CQCT/MD HS/NCA, Program Questions, P.O. Box 42716, Olympia, WA 98504-2716, phone 360-725-9805, fax 360-586-9727, TRS 711, email andrea.allen@hca.wa.gov, website www.hca.wa.gov/about-hca/rulemaking.